혈액가스 및 전해질 분석기 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 최종 용도별, 지역별, 부문별 예측(2024-2030년)

Blood Gas And Electrolyte Analyzer Market Size, Share & Trends Analysis Report By Products (Instruments, Consumables), By End-use (Clinical Laboratory, Point-of-care), By Region, And Segment Forecasts, 2024 - 2030

US $ 5,950 ￦ 8,888,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 10,381,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 13,369,000

Printable PDF & Excel (Enterprise License)

PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

한글목차

혈액가스 및 전해질 분석기 시장 성장과 동향:

Grand View Research Inc.의 새로운 연구에 따르면 세계 혈액가스 및 전해질 분석기 시장 규모는 연평균 4.5%의 CAGR을 기록하여 2030년까지 37억 1,000만 달러에 달할 것으로 예상됩니다.

중환자실 및 중환자실의 환자 수 증가와 고처리량 및 통합 시스템에 대한 수요 증가는 혈액가스 및 전해질 분석기 시장을 견인할 것으로 예상되는 주요 요인입니다. 또한, 전 세계 노인 인구의 증가는 대상 질환의 유병률을 높이고 중증 치료를 필요로 하는 환자의 저변을 확대함으로써 예측 기간 동안 시장 성장에 크게 기여할 것으로 예상됩니다. 또한, 검사 메뉴의 확대와 휴대용 기기에 대한 수요 증가로 인해 다중 매개 변수 모니터링 기기의 출현은 예측 기간 동안 사용률을 높일 것으로 예상됩니다. 혈액가스 분석기의 출시로 호흡기 질환의 빈번한 진단 및 모니터링이 가능해짐에 따라 예후 및 치료 지침에 도움이 되어 중증 환자 치료를 강화하는 데 도움이 되고 있습니다. 단시간에 측정할 수 있는 첨단 기술을 갖춘 핸드헬드 기기에 대한 수요가 증가함에 따라 더욱 작고 정교한 핸드헬드 POC(Point-of-Care)(Point of Care) 기기가 개발되고 있습니다. 예를 들어, OPTI CCA-TS2 혈액가스 및 전해질 분석기는 혁신적인 광학 기술을 사용하여 최소한의 유지보수로 빠른 결과를 제공합니다.

혈액가스 및 전해질 분석기 시장 보고서 하이라이트

• 2023년 매출 점유율은 소모품이 66.28%로 시장을 장악하고 예측 기간 동안 가장 빠른 성장률로 성장할 것으로 예상됩니다.
• 2023년 매출 점유율 46.98%, 임상 검사 분야가 시장을 장악했습니다. 빠르게 발전하는 의료 기술에서 혈액가스 분석기(BGA)는 임상 검사실에 필수적인 장비로, 환자의 호흡 및 대사 상태를 실시간으로 파악할 수 있습니다.
• 2023년 혈액가스 및 전해질 분석기 시장은 북미가 42.22%의 점유율을 차지했습니다. 정교한 의료 인프라의 존재와 유리한 상환 계획은 이 지역의 시장 성장을 촉진할 것으로 예상되는 주요 요인입니다.
• 인도와 중국 등 신흥 시장의 의료 인프라가 빠르게 개선되고 있는 가운데, 미충족 수요가 높다는 점이 예측 기간 동안 아시아태평양의 성장률을 견인할 것으로 예상됩니다. 대량의 진단 검사를 처리할 수 있는 분산형 현장 진단 시설에 대한 수요 증가도 이 지역의 시장 성장을 촉진할 것으로 예상됩니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 혈액가스 및 전해질 분석기 시장 변수, 동향, 범위

• 시장 계통 전망
  • 상부 시장 전망
  • 관련/부수 시장 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 혈액가스 및 전해질 분석기 시장 분석 툴
  • 업계 분석 - Porter's Five Forces 분석
  • PESTEL 분석

제4장 혈액가스 및 전해질 분석기 시장 : 제품별 추정·동향 분석

• 세계의 혈액가스 및 전해질 분석기 시장 : 제품별 대시보드
• 세계의 혈액가스 및 전해질 분석기 시장 : 제품별 변동 분석
• 세계의 혈액가스 및 전해질 분석기 시장 : 제품별, 매출별
• 기기
• 소모품

제5장 혈액가스 및 전해질 분석기 시장 : 최종 용도별 추정·동향 분석

• 세계의 혈액가스 및 전해질 분석기 시장 : 최종 용도별 대시보드
• 세계의 혈액가스 및 전해질 분석기 시장 : 최종 용도별 변동 분석
• 세계의 혈액가스 및 전해질 분석기 시장 : 최종 용도별, 매출별
• 임상 검사실
• POC(Point of Care)
• 진단 센터
• 기타

제6장 혈액가스 및 전해질 분석기 시장 : 제품 및 최종 용도 지역별 추정·동향 분석

• 지역 대시보드
• 시장 규모, 예측 동향 분석, 2018-2030년
• 북미
• 유럽
• 아시아태평양
• 라틴아메리카
• 중동 및 아프리카

제7장 경쟁 상황

• 주요 시장 진출 기업의 최근 동향과 영향 분석
• 기업/경쟁 분류
• 벤더 상황
  • 주요 판매대리점 및 채널 파트너 리스트
  • 주요 고객
  • 주요 기업의 시장 점유율 분석, 2023년
  • Abbott
  • Meizhou Cornley High-Tech Co., Ltd.
  • Radiometer Medical ApS
  • EDAN Instruments, Inc.
  • Erba Mannheim
  • F. Hoffmann-La Roche Ltd
  • Fortress Diagnostics
  • Werfen
  • LifeHealth
  • Medica Corporation
  • OPTI Medical Systems, Inc.,
  • Sensa Core
  • Siemens Healthineers AG

ksm

영문 목차

영문목차

Blood Gas And Electrolyte Analyzer Market Growth & Trends:

The global blood gas and electrolyte analyzer market size is expected to reach USD 3.71 billion by 2030, registering a CAGR of 4.5%, according to a new study by Grand View Research Inc. Rising number of patients in ICU and critical care units and increasing demand for high throughput and integrated systems are some key factors likely to drive the blood gas and electrolyte analyzers market. Growing global geriatric population base is also expected to significantly contribute towards market growth over the forecast period, by triggering the incidence rates of target diseases and widening the base of patients requiring critical care. Furthermore, the emergence of multi-parameter monitoring devices owing to, expanding test menus and growing demand for portable devices is expected to boost usage rates over the forecast period. The availability of blood gas analyzers has helped enhance the care of critically ill patients allowing for frequent diagnosis and monitoring of respiratory problems and ability to guide prognosis and therapy. Rising demand for technically advanced sleek handheld devices involving short turnaround time has resulted in the development of more compact, sleek, handheld point-of-care devices. For instance, the OPTI CCA-TS2 blood gas and electrolyte analyzers use innovative optical technology and provide fast results while requiring minimal maintenance.

Blood Gas And Electrolyte Analyzer Market Report Highlights:

• Consumables dominated the market with a revenue share of 66.28% in 2023 and is anticipated to grow at the fastest growth rate over the forecast period, driven by their increasing demand.
• Clinical laboratory dominated the market with a revenue market share of 46.98% in 2023. In the rapidly advancing landscape of healthcare technology, Blood Gas Analyzers (BGAs) have become indispensable for clinical laboratories, offering real-time insights into a patient's respiratory and metabolic status.
• North America accounted for 42.22% of the blood gas and electrolyte analyzers market in 2023. Presence of sophisticated healthcare infrastructure along with favorable reimbursement plans are some key factors expected to drive regional market growth.
• Presence of high unmet needs clubbed with rapidly improving healthcare infrastructure in the emerging markets of India and China is expected to help Asia Pacific grow at a lucrative rate throughout the forecast period. Growing demand for decentralized point-of-care diagnostic facilities handling large volumes of diagnostic tests is also expected to drive regional market growth.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. End Use
  • 1.2.3. Regional scope
  • 1.2.4. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product and end-use outlook
  • 2.2.2. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Blood Gas and Electrolyte Analyzer Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Growing prevalence of chronic diseases
    • 3.2.1.2. Rising geriatric population
    • 3.2.1.3. Increasing regulatory support and funding
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. High cost of advanced analyzers
    • 3.2.2.2. Shortage of skilled professionals
• 3.3. Blood Gas and Electrolyte Analyzer Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. Blood Gas and Electrolyte Analyzer Market: Product Estimates & Trend Analysis

• 4.1. Global Blood Gas and Electrolyte Analyzer Market: Product Dashboard
• 4.2. Global Blood Gas and Electrolyte Analyzer Market: Product Movement Analysis
• 4.3. Global Blood Gas and Electrolyte Analyzer Market by Product, Revenue
• 4.4. Instruments
  • 4.4.1. Instruments market estimates and forecasts 2018 - 2030 (USD Million)
  • 4.4.2. Instruments, by Type
  • 4.4.3. Bench Top
    • 4.4.3.1. Benchtop instruments market estimates and forecasts 2018 - 2030 (USD Million)
  • 4.4.4. Portable
    • 4.4.4.1. Portable instruments market estimates and forecasts 2018 - 2030 (USD Million)
  • 4.4.5. Instruments, by Brand
  • 4.4.6. I-STAT
    • 4.4.6.1. I-STAT market estimates and forecasts 2018 - 2030 (USD Million)
  • 4.4.7. epoc
    • 4.4.7.1. epoc market estimates and forecasts 2018 - 2030 (USD Million)
  • 4.4.8. GEM Premier (3500& 5000)
    • 4.4.8.1. GEM Premier (3500& 5000) market estimates and forecasts 2018 - 2030 (USD Million)
  • 4.4.9. ABL Flex (90 and 800)
    • 4.4.9.1. ABL Flex (90 and 800) market estimates and forecasts 2018 - 2030 (USD Million)
  • 4.4.10. Cobas
    • 4.4.10.1. Cobas market estimates and forecasts 2018 - 2030 (USD Million)
  • 4.4.11. Portable RAPID Series
    • 4.4.11.1. RAPID series market estimates and forecasts 2018 - 2030 (USD Million)
  • 4.4.12. Others
    • 4.4.12.1. Others market estimates and forecasts 2018 - 2030 (USD Million)
• 4.5. Consumables
  • 4.5.1. Consumables market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 5. Blood Gas and Electrolyte Analyzer Market: End Use Estimates & Trend Analysis

• 5.1. Global Blood Gas and Electrolyte Analyzer Market: End Use Dashboard
• 5.2. Global Blood Gas and Electrolyte Analyzer Market: End Use Movement Analysis
• 5.3. Global Blood Gas and Electrolyte Analyzer Market by End Use, Revenue
• 5.4. Clinical Laboratory
  • 5.4.1. Clinical laboratory market estimates and forecasts 2018 - 2030 (USD Million)
• 5.5. Point-of-care
  • 5.5.1. Point-of-care market estimates and forecasts 2018 - 2030 (USD Million)
• 5.6. Diagnostic Centers
  • 5.6.1. Diagnostic centers market estimates and forecasts 2018 - 2030 (USD Million)
• 5.7. Others
  • 5.7.1. Others market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 6. Blood Gas and Electrolyte Analyzer Market: Regional Estimates & Trend Analysis by Product and End Use

• 6.1. Regional Dashboard
• 6.2. Market Size, & Forecasts Trend Analysis, 2018 - 2030:
• 6.3. North America
  • 6.3.1. U.S.
    • 6.3.1.1. Key country dynamics
    • 6.3.1.2. Regulatory framework/ reimbursement structure
    • 6.3.1.3. Competitive scenario
    • 6.3.1.4. U.S. market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.3.2. Canada
    • 6.3.2.1. Key country dynamics
    • 6.3.2.2. Regulatory framework/ reimbursement structure
    • 6.3.2.3. Competitive scenario
    • 6.3.2.4. Canada market estimates and forecasts 2018 - 2030 (USD Million)
• 6.4. Europe
  • 6.4.1. UK
    • 6.4.1.1. Key country dynamics
    • 6.4.1.2. Regulatory framework/ reimbursement structure
    • 6.4.1.3. Competitive scenario
    • 6.4.1.4. UK market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.4.2. Germany
    • 6.4.2.1. Key country dynamics
    • 6.4.2.2. Regulatory framework/ reimbursement structure
    • 6.4.2.3. Competitive scenario
    • 6.4.2.4. Germany market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.4.3. France
    • 6.4.3.1. Key country dynamics
    • 6.4.3.2. Regulatory framework/ reimbursement structure
    • 6.4.3.3. Competitive scenario
    • 6.4.3.4. France market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.4.4. Italy
    • 6.4.4.1. Key country dynamics
    • 6.4.4.2. Regulatory framework/ reimbursement structure
    • 6.4.4.3. Competitive scenario
    • 6.4.4.4. Italy market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.4.5. Spain
    • 6.4.5.1. Key country dynamics
    • 6.4.5.2. Regulatory framework/ reimbursement structure
    • 6.4.5.3. Competitive scenario
    • 6.4.5.4. Spain market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.4.6. Norway
    • 6.4.6.1. Key country dynamics
    • 6.4.6.2. Regulatory framework/ reimbursement structure
    • 6.4.6.3. Competitive scenario
    • 6.4.6.4. Norway market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.4.7. Sweden
    • 6.4.7.1. Key country dynamics
    • 6.4.7.2. Regulatory framework/ reimbursement structure
    • 6.4.7.3. Competitive scenario
    • 6.4.7.4. Sweden market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.4.8. Denmark
    • 6.4.8.1. Key country dynamics
    • 6.4.8.2. Regulatory framework/ reimbursement structure
    • 6.4.8.3. Competitive scenario
    • 6.4.8.4. Denmark market estimates and forecasts 2018 - 2030 (USD Million)
• 6.5. Asia Pacific
  • 6.5.1. Japan
    • 6.5.1.1. Key country dynamics
    • 6.5.1.2. Regulatory framework/ reimbursement structure
    • 6.5.1.3. Competitive scenario
    • 6.5.1.4. Japan market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.5.2. China
    • 6.5.2.1. Key country dynamics
    • 6.5.2.2. Regulatory framework/ reimbursement structure
    • 6.5.2.3. Competitive scenario
    • 6.5.2.4. China market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.5.3. India
    • 6.5.3.1. Key country dynamics
    • 6.5.3.2. Regulatory framework/ reimbursement structure
    • 6.5.3.3. Competitive scenario
    • 6.5.3.4. India market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.5.4. Australia
    • 6.5.4.1. Key country dynamics
    • 6.5.4.2. Regulatory framework/ reimbursement structure
    • 6.5.4.3. Competitive scenario
    • 6.5.4.4. Australia market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.5.5. South Korea
    • 6.5.5.1. Key country dynamics
    • 6.5.5.2. Regulatory framework/ reimbursement structure
    • 6.5.5.3. Competitive scenario
    • 6.5.5.4. South Korea market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.5.6. Singapore
    • 6.5.6.1. Key country dynamics
    • 6.5.6.2. Regulatory framework/ reimbursement structure
    • 6.5.6.3. Competitive scenario
    • 6.5.6.4. Japan market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.5.7. Malaysia
    • 6.5.7.1. Key country dynamics
    • 6.5.7.2. Regulatory framework/ reimbursement structure
    • 6.5.7.3. Competitive scenario
    • 6.5.7.4. China market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.5.8. Indonesia
    • 6.5.8.1. Key country dynamics
    • 6.5.8.2. Regulatory framework/ reimbursement structure
    • 6.5.8.3. Competitive scenario
    • 6.5.8.4. India market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.5.9. Thailand
    • 6.5.9.1. Key country dynamics
    • 6.5.9.2. Regulatory framework/ reimbursement structure
    • 6.5.9.3. Competitive scenario
    • 6.5.9.4. Australia market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.5.10. Vietnam
    • 6.5.10.1. Key country dynamics
    • 6.5.10.2. Regulatory framework/ reimbursement structure
    • 6.5.10.3. Competitive scenario
    • 6.5.10.4. South Korea market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.5.11. Philippines
    • 6.5.11.1. Key country dynamics
    • 6.5.11.2. Regulatory framework/ reimbursement structure
    • 6.5.11.3. Competitive scenario
    • 6.5.11.4. South Korea market estimates and forecasts 2018 - 2030 (USD Million)
• 6.6. Latin America
  • 6.6.1. Brazil
    • 6.6.1.1. Key country dynamics
    • 6.6.1.2. Regulatory framework/ reimbursement structure
    • 6.6.1.3. Competitive scenario
    • 6.6.1.4. Brazil market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.6.2. Mexico
    • 6.6.2.1. Key country dynamics
    • 6.6.2.2. Regulatory framework/ reimbursement structure
    • 6.6.2.3. Competitive scenario
    • 6.6.2.4. Mexico market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.6.3. Argentina
    • 6.6.3.1. Key country dynamics
    • 6.6.3.2. Regulatory framework/ reimbursement structure
    • 6.6.3.3. Competitive scenario
    • 6.6.3.4. Argentina market estimates and forecasts 2018 - 2030 (USD Million)
• 6.7. MEA
  • 6.7.1. South Africa
    • 6.7.1.1. Key country dynamics
    • 6.7.1.2. Regulatory framework/ reimbursement structure
    • 6.7.1.3. Competitive scenario
    • 6.7.1.4. South Africa market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.7.2. Saudi Arabia
    • 6.7.2.1. Key country dynamics
    • 6.7.2.2. Regulatory framework/ reimbursement structure
    • 6.7.2.3. Competitive scenario
    • 6.7.2.4. Saudi Arabia market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.7.3. UAE
    • 6.7.3.1. Key country dynamics
    • 6.7.3.2. Regulatory framework/ reimbursement structure
    • 6.7.3.3. Competitive scenario
    • 6.7.3.4. UAE market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.7.4. Kuwait
    • 6.7.4.1. Key country dynamics
    • 6.7.4.2. Regulatory framework/ reimbursement structure
    • 6.7.4.3. Competitive scenario
    • 6.7.4.4. Kuwait market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis, By Key Market Participants
• 7.2. Company/Competition Categorization
• 7.3. Vendor Landscape
  • 7.3.1. List of key distributors and channel partners
  • 7.3.2. Key customers
  • 7.3.3. Key company market share analysis, 2023
  • 7.3.4. Abbott
    • 7.3.4.1. Company overview
    • 7.3.4.2. Financial performance
    • 7.3.4.3. Product benchmarking
    • 7.3.4.4. Strategic initiatives
  • 7.3.5. Meizhou Cornley High-Tech Co., Ltd.
    • 7.3.5.1. Company overview
    • 7.3.5.2. Financial performance
    • 7.3.5.3. Product benchmarking
    • 7.3.5.4. Strategic initiatives
  • 7.3.6. Radiometer Medical ApS
    • 7.3.6.1. Company overview
    • 7.3.6.2. Financial performance
    • 7.3.6.3. Product benchmarking
    • 7.3.6.4. Strategic initiatives
  • 7.3.7. EDAN Instruments, Inc.
    • 7.3.7.1. Company overview
    • 7.3.7.2. Financial performance
    • 7.3.7.3. Product benchmarking
    • 7.3.7.4. Strategic initiatives
  • 7.3.8. Erba Mannheim
    • 7.3.8.1. Company overview
    • 7.3.8.2. Financial performance
    • 7.3.8.3. Product benchmarking
    • 7.3.8.4. Strategic initiatives
  • 7.3.9. F. Hoffmann-La Roche Ltd
    • 7.3.9.1. Company overview
    • 7.3.9.2. Financial performance
    • 7.3.9.3. Product benchmarking
    • 7.3.9.4. Strategic initiatives
  • 7.3.10. Fortress Diagnostics
    • 7.3.10.1. Company overview
    • 7.3.10.2. Financial performance
    • 7.3.10.3. Product benchmarking
    • 7.3.10.4. Strategic initiatives
  • 7.3.11. Werfen
    • 7.3.11.1. Company overview
    • 7.3.11.2. Financial performance
    • 7.3.11.3. Product benchmarking
    • 7.3.11.4. Strategic initiatives
  • 7.3.12. LifeHealth
    • 7.3.12.1. Company overview
    • 7.3.12.2. Financial performance
    • 7.3.12.3. Product benchmarking
    • 7.3.12.4. Strategic initiatives
  • 7.3.13. Medica Corporation
    • 7.3.13.1. Company overview
    • 7.3.13.2. Financial performance
    • 7.3.13.3. Product benchmarking
    • 7.3.13.4. Strategic initiatives
  • 7.3.14. OPTI Medical Systems, Inc.,
    • 7.3.14.1. Company overview
    • 7.3.14.2. Financial performance
    • 7.3.14.3. Product benchmarking
    • 7.3.14.4. Strategic initiatives
  • 7.3.15. Sensa Core
    • 7.3.15.1. Company overview
    • 7.3.15.2. Financial performance
    • 7.3.15.3. Product benchmarking
    • 7.3.15.4. Strategic initiatives
  • 7.3.16. Siemens Healthineers AG
    • 7.3.16.1. Company overview
    • 7.3.16.2. Financial performance
    • 7.3.16.3. Product benchmarking
    • 7.3.16.4. Strategic initiatives

관련자료